vix.ing · top · new · best · stats

CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions

2018/01/29 by Masao Hashimoto, Alice O. Kamphorst, Se Jin Im +6 · 675 citations
Immunology and Microbiology · Medicine · #Antigen #Biology #Blockade #CAR-T cell therapy research #CD8 #Cancer Immunotherapy and Biomarkers #Cancer research #Cell biology #Cell therapy #Cytotoxic T cell #Effector #Immune Cell Function and Interaction #Immune system #Immunology #In vitro #Internal medicine #Medicine #Receptor #Stem cell #T cell #T-cell receptor

paper · pdf · doi:10.1146/annurev-med-012017-043208

published in Annual Review of Medicine 69(1), 301-318 (Annual Reviews)

openalex publication_date 2018/01/29 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Abstract

Antigen-specific CD8 T cells are central to the control of chronic infections and cancer, but persistent antigen stimulation results in T cell exhaustion. Exhausted CD8 T cells have decreased effector function and proliferative capacity, partly caused by overexpression of inhibitory receptors such as programmed cell death (PD)-1. Blockade of the PD-1 pathway has opened a new therapeutic avenue for reinvigorating T cell responses, with positive outcomes especially for patients with cancer. Other strategies to restore function in exhausted CD8 T cells are currently under evaluation—many in combination with PD-1-targeted therapy. Exhausted CD8 T cells comprise heterogeneous cell populations with unique differentiation and functional states. A subset of stem cell–like PD-1 + CD8 T cells responsible for the proliferative burst after PD-1 therapy has been recently described. A greater understanding of T cell exhaustion is imperative to establish rational immunotherapeutic interventions.

Citations

Cited by

Related